Key result
Baseline intubation is linked to ~115% higher long-term MACCE after emergent PCI for ULMCA occlusion.
Why the study?
The long-term prognosis of patients who survive to discharge after emergent PCI for acute total or subtotal ULMCA occlusion remains unclear.
What are the long-term clinical outcomes and predictors of MACCE in patients surviving to discharge after emergent PCI for acute total/subtotal ULMCA occlusion?
Cohort (n=61)
Yes
What are the long-term clinical outcomes and predictors of MACCE in patients surviving to discharge after emergent PCI for acute total/subtotal ULMCA occlusion?
Hazard Ratio: 2.15 (95% CI 1.1–4.24)
p-value: p=0.03
Patients surviving to discharge after emergent PCI for acute ULMCA occlusion face a high long-term risk of MACCE, particularly those requiring intratracheal intubation at presentation.
High long-term MACCE rates in survivors support vigilant post-discharge monitoring; leaves open optimal strategies pending prospective data.
BACKGROUND: Acute total or subtotal occlusion of the unprotected left main coronary artery (ULMCA) is a rare but severe condition with high short-term mortality. However, the long-term prognosis of patients who survive to discharge after emergent percutaneous coronary intervention (PCI) remains unclear. This study aimed to evaluate long-term clinical outcomes in this population. METHODS: This multicenter retrospective study analyzed 61 patients who survived to discharge after emergent PCI for acute total/subtotal ULMCA occlusion. The primary endpoint was major adverse cardiac or cerebrovascular events (MACCE), including all-cause mortality, target vessel revascularization, heart failure hospitalization, and stroke. Predictors of MACCE were assessed using Cox proportional hazards regression. RESULTS: The median age of the study cohort was 73 (63-77) years, and 72.1% were male. During a median follow-up of 5.4 (1.0-9.2) years from the date of discharge, MACCE occurred in 38 patients (62.3%). The MACCE rates at 5 and 10 years were 58.6% and 74.6%, respectively. The corresponding all-cause mortality rates were 33.5% and 47.4%. Cardiac death was observed in eight patients (13.1%), while 14 patients (23.0%) died from noncardiac causes. Among the clinical and procedural factors assessed, only intratracheal intubation at presentation was identified as an independent predictor of MACCE (adjusted hazard ratio: 2.15, 95% confidence interval: 1.10-4.24, p = 0.03). CONCLUSIONS: These findings suggest the importance of post-discharge management strategies for patients who underwent emergent PCI for acute total/subtotal ULMCA occlusion due to the persistent risk of cardiac or cerebrovascular events.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (2025) conducted a cohort in Acute total or subtotal occlusion of the unprotected left main coronary artery (ULMCA) (n=61). Intratracheal intubation at presentation vs. No intratracheal intubation was evaluated on Major adverse cardiac or cerebrovascular events (MACCE), including all-cause mortality, target vessel revascularization, heart failure hospitalization, and stroke (HR 2.15, 95% CI 1.10-4.24, p=0.03). In patients surviving emergent PCI for acute ULMCA occlusion, intratracheal intubation at presentation independently predicted long-term MACCE (HR 2.15; 95% CI 1.10-4.24; p=0.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: